Population-Based FIT Screening Can Reduce CRC Mortality

This article originally appeared here.
Share this content:
Population-Based FIT Screening Can Reduce CRC Mortality
Population-Based FIT Screening Can Reduce CRC Mortality

THURSDAY, May 28, 2015 (HealthDay News) -- Population-based fecal immunochemical testing (FIT) screening in adults aged 50 to 69 years can reduce colorectal cancer (CRC) mortality, according to a study published online May 20 in Cancer.

Han-Mo Chiu, Ph.D., from National Taiwan University, and colleagues conducted a prospective study of the follow-up of about five million Taiwanese from 2004 to 2009. CRC mortality was compared for a screened group and an unscreened group in a population-based CRC screening service targeting 50- to 69-year-olds. Overall, 21.4 percent of the 5,417,699 subjects aged 50 to 69 years in the population participated in the biennial screening program by 2009.

The researchers found that, with a maximum follow-up of six years, the actual effectiveness of FIT in reducing CRC mortality was 62 percent (relative rate for screened versus unscreened group, 0.38). After adjustment for self-selection bias, the 21.4 percent coverage of the population receiving FIT correlated with a significant 10 percent reduction in CRC mortality (relative rate, 0.9).

"Although such findings are informative for health decision makers, continued follow-up of this large cohort will be required to estimate the long-term impact of FIT screening if the covered population is expanded," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »